Bibliographie (2530)
Cohort Study: Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism.
mardi, 03 mai 2022 13:54 Écrit par Zouhair SouissiChronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study – European Heart Journal Commentary on Twitter Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study https://t.co/IOvHAzKwa2 #EHJ #ESCYoung @ehj_ed @rladeiraslopes pic.twitter.com/ADFp09rooI — European Society of Cardiology Journals (@ESC_Journals) May 2, 2022
The post Cohort Study: Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism. appeared first on Links Medicus.
RCT: Effects of an online breathing and wellbeing program for people with persistent symptoms following COVID-19.
mardi, 03 mai 2022 13:53 Écrit par Zouhair SouissiAn online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial – The Lancet Respiratory Medicine Invited Commentary: Treating COVID-19-related breathlessness with novel interventions – The Lancet Respiratory Medicine News Release: Singing techniques can improve quality of life and breathlessness after COVID-19 – Imperial College […]
The post RCT: Effects of an online breathing and wellbeing program for people with persistent symptoms following COVID-19. appeared first on Links Medicus.
Systematic Review: Telerehabilitation improves physical function and reduces dyspnea in people with COVID-19 and post-COVID-19 conditions.
mardi, 03 mai 2022 13:53 Écrit par Zouhair SouissiTelerehabilitation improves physical function and reduces dyspnoea in people with COVID-19 and post-COVID-19 conditions: a systematic review – Journal of Physiotherapy
The post Systematic Review: Telerehabilitation improves physical function and reduces dyspnea in people with COVID-19 and post-COVID-19 conditions. appeared first on Links Medicus.
Remdesivir and three other drugs for hospitalized patients with COVID-19: final results of the WHO Solidarity randomized trial and updated meta-analyses.
mardi, 03 mai 2022 13:53 Écrit par Zouhair SouissiRemdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses – The Lancet Invited Commentary: When and which patients should receive remdesivir? – The Lancet
The post Remdesivir and three other drugs for hospitalized patients with COVID-19: final results of the WHO Solidarity randomized trial and updated meta-analyses. appeared first on Links Medicus.
Review: Novel approaches to imaging the pulmonary vasculature and right heart.
lundi, 02 mai 2022 05:42 Écrit par Zouhair SouissiNovel Approaches to Imaging the Pulmonary Vasculature and Right Heart – Circulation Research (free for a limited period)
The post Review: Novel approaches to imaging the pulmonary vasculature and right heart. appeared first on Links Medicus.
ATS/ERS/JRS/ALAT Guideline: Idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults.
lundi, 02 mai 2022 05:42 Écrit par Zouhair SouissiIdiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline – American Journal of Respiratory and Critical Care Medicine Commentary on Twitter (thread – click for more) ?Finally out online: the latest multisocietal guidance defining progression in fibrotic lung disease? has arrived! These long-awaited guidelines help better […]
The post ATS/ERS/JRS/ALAT Guideline: Idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults. appeared first on Links Medicus.
Pfizer says COVID treatment Paxlovid fails to prevent infection of household members.
lundi, 02 mai 2022 05:42 Écrit par Zouhair SouissiPfizer says COVID treatment Paxlovid fails to prevent infection of household members – Reuters Commentary on Twitter Pfizer Inc on Friday said a large trial found that its COVID-19 oral antiviral treatment Paxlovid was not effective at preventing coronavirus infection in people living with someone who had been exposed to the virus. https://t.co/95zphEYaxc — […]
The post Pfizer says COVID treatment Paxlovid fails to prevent infection of household members. appeared first on Links Medicus.
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews.
vendredi, 29 avril 2022 14:23 Écrit par Zouhair SouissiDisease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews – European Respiratory Review
The post Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews. appeared first on Links Medicus.
E-cigarettes and nicotine abstinence: a meta-analysis of randomized controlled trials.
vendredi, 29 avril 2022 14:23 Écrit par Zouhair SouissiE-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials – European Respiratory Review
The post E-cigarettes and nicotine abstinence: a meta-analysis of randomized controlled trials. appeared first on Links Medicus.
RCT: Effect of an interdisciplinary weight loss and lifestyle intervention on obstructive sleep apnea severity.
vendredi, 29 avril 2022 14:23 Écrit par Zouhair SouissiEffect of an Interdisciplinary Weight Loss and Lifestyle Intervention on Obstructive Sleep Apnea Severity: The INTERAPNEA Randomized Clinical Trial – JAMA Network Open Commentary: Weight Loss, Lifestyle Interventions Improve Obstructive Sleep Apnea – HCP Live Commentary on Twitter This RCT found a weight loss & lifestyle intervention for adults with CPAP-treated moderate-to-severe OSA resulted […]
The post RCT: Effect of an interdisciplinary weight loss and lifestyle intervention on obstructive sleep apnea severity. appeared first on Links Medicus.
